Search Results 401-410 of 16598 for ������������KA���:ZA31���24������ ���������������������������������
... 24; Month 6) Visit 9 (Week 52; Month 12). Visit 10 (Week 104, Month 24). A Study to Understand the Mechanisms of Normal and Disordered Defection. Rochester ...
Participation eligibility · Calculated creatinine clearance ≥30 mL/min using a modified Cockcroft-Gault calculation or a 24-hour urine collection for Creatinine ...
Non-elective VAD placement (VAD implantation decision made within 24 hours). Participating Mayo Clinic locations. Study statuses change often. Please contact ...
Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung ...
About this study. This open-label study will evaluate safety, pharmacokinetics and efficacy of a 12 or 24 week regimen of ombitasvir/ABT-450/ritonavir and ...
Participation eligibility · Has not undergone hysterectomy or bilateral oophorectomy or · Has not been naturally postmenopausal for at least 24 consecutive months ...
Jacksonville, Florida: 24-007175. About this study. The purpose of this study is to test the feasibility of NanoString digital spatial profiling (DSP) and ...
... KA, Fuentes Bayne HE, Rwigema JCM, Patel SH ... 2017 Jun; 70 (7):1021-1029 Epub 2017 Jan 24. View ... Epub 2017 Jan 13. View PubMed; Janus JR, Jackson RS, Lees KA ...
... 24 +/- 4 hours following the end of AFP-464 infusion; International normalized ratio (INR) ≤ 1.4; If taking aspirin, must discontinue ≥ 5 days prior to ...
In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 21st ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 24, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.